Lymphatic dysfunction in lupus contributes to cutaneous photosensitivity and lymph node B cell responses.

Area of Science:

• Immunology
• Dermatology
• Lymphatic System Biology

Background:

• Systemic lupus erythematosus (SLE) patients exhibit photosensitivity, where ultraviolet radiation (UVR) triggers skin inflammation and can lead to systemic disease flares.
• The mechanistic link between cutaneous photosensitivity and the development of systemic autoimmunity in SLE remains poorly understood.
• Lymphatic vessels are key conduits for immune cell trafficking and communication between the skin and draining lymph nodes.

Purpose of the Study:

• To investigate the role of lymphatic vessels in transmitting signals from UVR-exposed skin to the immune system in SLE.
• To explore the therapeutic potential of modulating lymphatic flow in managing SLE-associated photosensitivity and autoimmunity.
• To elucidate the mechanisms by which lymphatic function influences immune responses in the lymph nodes.

Main Methods:

• Assessed UVR-induced lymphatic flow dysfunction in SLE patients and murine models.
• Utilized manual lymphatic drainage (MLD) and a transgenic mouse model with enhanced lymphatic vessels.
• Analyzed cutaneous inflammation, lymph node B and T cell responses, splenomegaly, and autoantibody titers.
• Investigated the role of the fibroblastic reticular cell-monocyte axis in lymph nodes.

Main Results:

• UVR exposure potentiates lymphatic flow dysfunction in both SLE patients and murine models.
• Improving lymphatic flow via MLD or increased lymphatic vessel density reduced skin inflammation and lymph node immune cell activation.
• Long-term MLD treatment decreased splenomegaly and autoantibody levels in lupus models.
• Enhanced lymphatic flow was shown to restrain B cell responses partly through a lymph node fibroblastic reticular cell-monocyte axis.

Conclusions:

• Lymphatic vessel dysfunction plays a significant role in linking photosensitive skin inflammation to systemic autoimmunity in SLE.
• Modulating lymphatic function, particularly through MLD, represents a promising therapeutic strategy for SLE.
• The findings highlight the skin-lymphatic-lymph node axis as a critical pathway in SLE pathogenesis and suggest MLD as a cost-effective adjunct therapy.